143 related articles for article (PubMed ID: 2102478)
1. Early diagnosis for bone metastasis of breast cancer based on bone metabolism.
Suzuki S
Fukushima J Med Sci; 1990 Jun; 36(1):11-27. PubMed ID: 2102478
[TBL] [Abstract][Full Text] [Related]
2. [Study of bone metabolism for breast cancer by MD (microdensitometry) method].
Suzuki S; Kimijima I; Nihei M; Mizunuma H; Kiman K; Hatakeyama Y; Nomizu T; Tsuchiya A; Abe R
Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2459-67. PubMed ID: 2262729
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of serum osteocalcin in patients with bone metastasis of breast cancer].
Suzuki S; Nomizu T; Nihei M; Rokkaku Y; Kimijima I; Tsuchiya A; Abe R
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2386-93. PubMed ID: 2614177
[TBL] [Abstract][Full Text] [Related]
4. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
Koizumi M; Yonese J; Fukui I; Ogata E
J Urol; 2002 Apr; 167(4):1863-6. PubMed ID: 11912449
[TBL] [Abstract][Full Text] [Related]
5. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
6. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
7. Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients.
Zissimopoulos A; Matthaios D; Matthaiou E; Mantadakis E; Karaitianos I
J BUON; 2007; 12(4):505-11. PubMed ID: 18067209
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of bone scintigraphy for early detection of bone metastasis from breast cancer].
Wada T; Hohjoh T; Matunami N; Yamato M; Kadota K; Morikawa E; Hara S; Matsuda T; Yasutomi M
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):781-5. PubMed ID: 2778373
[TBL] [Abstract][Full Text] [Related]
9. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers for assessment of bone metastases in patients with breast cancer.
Hou MF; Tsai LY; Tsai SM; Huang CJ; Huang YS; Hsieh JS; Chan HM; Wang JY; Chuang CH; Chen FM; Huang TJ
Kaohsiung J Med Sci; 1999 Aug; 15(8):452-60. PubMed ID: 10518361
[TBL] [Abstract][Full Text] [Related]
11. [Studies on prognosis of prostate cancer with bone metastasis by using pretreatment bone scintigraphy].
Kubota Y; Numasawa K; Suzuki H; Kakizaki H; Suzuki K
Hinyokika Kiyo; 1989 Oct; 35(10):1693-9. PubMed ID: 2610178
[TBL] [Abstract][Full Text] [Related]
12. The status of nuclear medicine techniques in the diagnosis of bone metastases in breast cancer.
Makaiová I; Kausitz J; Hupka S; Michaliková B; Vivodová M; Bohunický L
Czech Med; 1989; 12(1):34-9. PubMed ID: 2498049
[TBL] [Abstract][Full Text] [Related]
13. Cross-linked collagen C- and N-telopeptides for an early diagnosis of bone metastasis from breast cancer.
Kiuchi K; Ishikawa T; Hamaguchi Y; Momiyama N; Hasegawa S; Ishiyama A; Kono T; Doi T; Chishima T; Shimada H
Oncol Rep; 2002; 9(3):595-8. PubMed ID: 11956634
[TBL] [Abstract][Full Text] [Related]
14. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
[TBL] [Abstract][Full Text] [Related]
15. Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer.
Pecherstorfer M; Schilling T; Janisch S; Woloszczuk W; Baumgartner G; Ziegler R; Ogris E
J Nucl Med; 1993 Jul; 34(7):1039-44. PubMed ID: 8315476
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of occult skeletal metastasis: alkaline phosphatase versus skeletal scintigraphy].
Zieger M
Med Klin Prax; 1982 May; 77(11):44-50. PubMed ID: 7099105
[TBL] [Abstract][Full Text] [Related]
17. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
[TBL] [Abstract][Full Text] [Related]
18. [Bone metabolism and phosphorus metabolism in patients with prostate cancer: paracrine and endocrine effects produced by prostate neoplasm].
Satani H; Yamakawa K; Kawamura J; Mori O; Saito K; Kato H; Tochigi H; Sakurai M; Kato T
Hinyokika Kiyo; 1997 Dec; 43(12):849-54. PubMed ID: 9488931
[TBL] [Abstract][Full Text] [Related]
19. [Study on carbohydrate antigen NCC-ST-439 in breast cancer].
Suzuki S; Nihei M; Nomizu T; Watanabe T; Kimijima I; Tsuchiya A; Abe R
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):1019-26. PubMed ID: 2202768
[TBL] [Abstract][Full Text] [Related]
20. [Scintigraphy in breast cancer].
Morita R; Fukunaga M; Otsuka N
Gan No Rinsho; 1986 Jan; Suppl():163-76. PubMed ID: 3959327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
